2016 Q2 Form 10-Q Financial Statement

#000119312516664629 Filed on July 29, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $47.35M $38.85M
YoY Change 21.89% 24.91%
Cost Of Revenue $15.97M $12.34M
YoY Change 29.49% 28.13%
Gross Profit $31.38M $26.51M
YoY Change 18.36% 23.46%
Gross Profit Margin 66.27% 68.25%
Selling, General & Admin $23.76M $20.16M
YoY Change 17.88% 22.81%
% of Gross Profit 75.72% 76.03%
Research & Development $5.542M $4.495M
YoY Change 23.29% 33.58%
% of Gross Profit 17.66% 16.96%
Depreciation & Amortization $2.830M $2.400M
YoY Change 17.92% 9.09%
% of Gross Profit 9.02% 9.05%
Operating Expenses $30.50M $25.48M
YoY Change 19.68% 24.56%
Operating Profit $880.0K $1.027M
YoY Change -14.31% 1.28%
Interest Expense $150.0K $40.00K
YoY Change 275.0% -20.0%
% of Operating Profit 17.05% 3.89%
Other Income/Expense, Net -$223.0K -$20.00K
YoY Change 1015.0% -123.53%
Pretax Income $657.0K $1.007M
YoY Change -34.76% -8.37%
Income Tax $305.0K $356.0K
% Of Pretax Income 46.42% 35.35%
Net Earnings $352.0K $651.0K
YoY Change -45.93% 1.88%
Net Earnings / Revenue 0.74% 1.68%
Basic Earnings Per Share $0.02 $0.04
Diluted Earnings Per Share $0.02 $0.04
COMMON SHARES
Basic Shares Outstanding 16.91M shares 16.54M shares
Diluted Shares Outstanding 17.12M shares 17.00M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $128.2M $121.3M
YoY Change 5.69% -11.14%
Cash & Equivalents $107.2M $121.3M
Short-Term Investments $21.00M
Other Short-Term Assets $7.540M $6.393M
YoY Change 17.94% -57.38%
Inventory
Prepaid Expenses
Receivables $20.43M $17.26M
Other Receivables $0.00 $0.00
Total Short-Term Assets $173.4M $159.1M
YoY Change 9.02% -3.53%
LONG-TERM ASSETS
Property, Plant & Equipment $13.93M $12.95M
YoY Change 7.57% 43.34%
Goodwill $50.85M $34.30M
YoY Change 48.24% 34.59%
Intangibles
YoY Change
Long-Term Investments $7.600M $10.00M
YoY Change -24.0%
Other Assets $2.213M $365.0K
YoY Change 506.3% 78.05%
Total Long-Term Assets $114.3M $90.86M
YoY Change 25.84% 39.17%
TOTAL ASSETS
Total Short-Term Assets $173.4M $159.1M
Total Long-Term Assets $114.3M $90.86M
Total Assets $287.8M $249.9M
YoY Change 15.14% 8.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.581M $3.706M
YoY Change -3.37% 23.57%
Accrued Expenses $3.887M $2.129M
YoY Change 82.57% 17.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $33.15M $23.84M
YoY Change 39.04% 23.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $15.40M $14.20M
YoY Change 8.45% 11.81%
Total Long-Term Liabilities $15.40M $14.20M
YoY Change 8.45% 11.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.15M $23.84M
Total Long-Term Liabilities $15.40M $14.20M
Total Liabilities $50.91M $38.01M
YoY Change 33.93% 18.66%
SHAREHOLDERS EQUITY
Retained Earnings -$38.05M -$42.85M
YoY Change -11.2% -6.4%
Common Stock $276.5M $257.3M
YoY Change 7.44% 5.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $236.8M $211.9M
YoY Change
Total Liabilities & Shareholders Equity $287.8M $249.9M
YoY Change 15.14% 8.58%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income $352.0K $651.0K
YoY Change -45.93% 1.88%
Depreciation, Depletion And Amortization $2.830M $2.400M
YoY Change 17.92% 9.09%
Cash From Operating Activities $1.880M -$670.0K
YoY Change -380.6% -119.82%
INVESTING ACTIVITIES
Capital Expenditures -$950.0K -$2.770M
YoY Change -65.7% 9.92%
Acquisitions
YoY Change
Other Investing Activities -$6.120M -$9.990M
YoY Change -38.74%
Cash From Investing Activities -$7.080M -$12.76M
YoY Change -44.51% 406.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.870M 1.190M
YoY Change 57.14% 14.42%
NET CHANGE
Cash From Operating Activities 1.880M -670.0K
Cash From Investing Activities -7.080M -12.76M
Cash From Financing Activities 1.870M 1.190M
Net Change In Cash -3.330M -12.24M
YoY Change -72.79% -744.21%
FREE CASH FLOW
Cash From Operating Activities $1.880M -$670.0K
Capital Expenditures -$950.0K -$2.770M
Free Cash Flow $2.830M $2.100M
YoY Change 34.76% -64.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130795000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11150000
CY2015Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
87235000
CY2015Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
28990000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16723994 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16723994 shares
CY2015Q4 us-gaap Assets
Assets
261731000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
4307000
CY2015Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1194000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
166786000
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
61000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2015Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
102185000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
265265000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
446000
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
7517000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121538000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
11149000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17615000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
17000
CY2015Q4 us-gaap Deferred Costs
DeferredCosts
5260000
CY2015Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
15086000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
11005000
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
102244000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2163000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7740000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3648000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1987000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13909000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5030000
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Liabilities
Liabilities
39546000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
261731000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15081000
CY2015Q4 us-gaap Goodwill
Goodwill
33848000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24234000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1037000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
14950000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13620000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
222185000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.91
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39449000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
943103 shares
CY2015Q4 spsc Available For Sale Securities Debt Maturities Within Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinTwoYearsFairValue
14950000
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16977720 shares
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121344000
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12053000
CY2016Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
87278000
CY2016Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
38833000
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16945460 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16945460 shares
CY2016Q2 us-gaap Assets
Assets
287755000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3852000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4441000
CY2016Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
4140000
CY2016Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
1344000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
173420000
CY2016Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
73000
CY2016Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
33000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17500000
CY2016Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
94834000
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
276462000
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
414000
CY2016Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
21010000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
107160000
CY2016Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
11588000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3560000
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
20432000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
17000
CY2016Q2 us-gaap Deferred Costs
DeferredCosts
5660000
CY2016Q2 us-gaap Deferred Costs Current
DeferredCostsCurrent
17278000
CY2016Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
11236000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2389000
CY2016Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
94794000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3581000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
12281000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5071000
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3221000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1584000
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2391000
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3887000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
15058000
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1717000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3219000
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
16299000
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
7540000
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q2 us-gaap Liabilities
Liabilities
50913000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
287755000
us-gaap Cost Of Revenue
CostOfRevenue
23907000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1678000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
22534000
CY2016Q2 us-gaap Goodwill
Goodwill
50852000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
33146000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2051000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1770000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3115000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2213000
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
7556000
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3186000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13932000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
33.39
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
236842000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
42.21
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
641204 shares
CY2016Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38053000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3900000 shares
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1142118 shares
CY2016Q2 spsc Available For Sale Securities Debt Maturities Within Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinTwoYearsFairValue
7556000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
400000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39000 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-9451000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-307000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3146000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11873000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3109000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
155000
us-gaap Revenues
Revenues
75816000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
2126000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-95000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-169000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-324000
us-gaap Gross Profit
GrossProfit
51909000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1334000
us-gaap Operating Expenses
OperatingExpenses
49960000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
741000
us-gaap Net Income Loss
NetIncomeLoss
1237000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9989000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
518000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1854000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-286000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15068000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2577000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2397000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
125000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2710000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
531000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
1949000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
74000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3537000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
671000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-409000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
617000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2387000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5079000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17043000 shares
us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
3000 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
24000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16485000 shares
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
6000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8564000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2396000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27845000
us-gaap Share Based Compensation
ShareBasedCompensation
3146000
dei Entity Registrant Name
EntityRegistrantName
SPS COMMERCE INC
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1421000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001092699
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14378000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
5000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3992000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14367000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3259000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2359000
us-gaap Cost Of Revenue
CostOfRevenue
30853000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-72000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-439000
us-gaap Revenues
Revenues
92950000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
2592000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
215000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-81000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
464000
us-gaap Gross Profit
GrossProfit
62097000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3460000
us-gaap Operating Expenses
OperatingExpenses
59903000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
786000
us-gaap Net Income Loss
NetIncomeLoss
1396000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8499000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
592000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2409000
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-17000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-27131000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1965000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2495000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18062000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
719000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3138000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
226000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
2194000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
296000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3956000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4325000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
439000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1013000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
8792000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
15600000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3070000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
99460 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Use of Estimates</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods.&#xA0;Actual results could differ from those estimates.</p> </div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17100000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
48.46
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
1000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
55.09
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
17.58
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16873000 shares
dei Trading Symbol
TradingSymbol
SPSC
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
99000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10611000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
Seven to ten years
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1749000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
337712 shares
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2500000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.09
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
32566000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
39237 shares
us-gaap Share Based Compensation
ShareBasedCompensation
3992000
spsc Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unissued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndUnissuedInPeriod
16058 shares
spsc Number Of Offerings
NumberOfOfferings
2 OfferingPeriods
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
315000 shares
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1647000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6055000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2015Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
833000
CY2015Q2 us-gaap Cost Of Revenue
CostOfRevenue
12335000
CY2015Q2 us-gaap Revenues
Revenues
38846000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-57000
CY2015Q2 us-gaap Gross Profit
GrossProfit
26511000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-621000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
25484000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
651000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1007000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1278000
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
436000 shares
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1027000
CY2015Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
37000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
356000
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16998000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
2000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
24000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16536000 shares
CY2015Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
6000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4495000
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14101000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
315000 shares
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2065000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7082000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1198000
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
15972000
CY2016Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
293000
CY2016Q2 us-gaap Revenues
Revenues
47351000
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-223000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-374000
CY2016Q2 us-gaap Gross Profit
GrossProfit
31379000
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-480000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
30499000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
352000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
657000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-856000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
209000 shares
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
880000
CY2016Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
151000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
305000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17120000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
2000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16909000 shares
CY2016Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
24000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5542000
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16677000

Files In Submission

Name View Source Status
0001193125-16-664629-index-headers.html Edgar Link pending
0001193125-16-664629-index.html Edgar Link pending
0001193125-16-664629.txt Edgar Link pending
0001193125-16-664629-xbrl.zip Edgar Link pending
d211310d10q.htm Edgar Link pending
d211310dex311.htm Edgar Link pending
d211310dex312.htm Edgar Link pending
d211310dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spsc-20160630.xml Edgar Link completed
spsc-20160630.xsd Edgar Link pending
spsc-20160630_cal.xml Edgar Link unprocessable
spsc-20160630_def.xml Edgar Link unprocessable
spsc-20160630_lab.xml Edgar Link unprocessable
spsc-20160630_pre.xml Edgar Link unprocessable